Improving the use of intravenous bisphosphonates in women with breast cancer metastatic to bone

J Natl Compr Canc Netw. 2014 Feb:12 Suppl 1:S40-1. doi: 10.6004/jnccn.2014.0214.

Abstract

The City of Hope Comprehensive Cancer Center has a long commitment to the creation of and adherence to treatment guidelines. The NCCN Opportunities for Improvement project provided the institution with a report card for adherence to the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer and the opportunity to determine reasons for nonconcurrence and improve concurrence rates. The institution focused on improving compliance with the use of intravenous bisphosphonates in women with metastatic bone disease.

MeSH terms

  • Administration, Intravenous
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Diphosphonates / administration & dosage
  • Diphosphonates / therapeutic use*
  • Female
  • Guideline Adherence
  • Humans
  • Patient Compliance
  • Quality Assurance, Health Care*
  • Quality Improvement*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates